PRKAA2 and neoplasm: The study by Ouyang et al. highlighted that PRKAA2 facilitates immune escape in tumor cells by reducing CD8+ T cells and promoting the generation of regulatory T cells (Tregs), thereby contributing to tumor progression [68].